Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can daily texts boost resilience in kids with cancer?

NCT ID NCT04902313

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a 12-week mobile phone program of daily reflection and meditation exercises for children with cancer and their families. The goal was to see if the program is practical and helpful for improving mental well-being and reducing anxiety and depression. Forty participants were enrolled, and the study focused on whether people would use the program and find it beneficial.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Awareness and Insight Modules (AiM) – a mobile phone-based program of daily reflection and meditation exercises
What this could lead to
If it works, this could offer a simple, low-cost way to support the mental well-being of children with cancer and their families during treatment.
What could go wrong
This is a very early feasibility study with only 40 participants, so results may not apply to all patients. The program may not provide meaningful benefits or be difficult to stick with long-term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 1

The first testing in people. Mainly checks safety and dose, usually in a small group.

Participants

40 people

The number who actually took part.

Started

May 2021

Finished

Dec 2023

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

10 to 18 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Newly diagnosed cancer * Chronic pediatric disease Exclusion Criteria: * Severe crisis reaction * Late-stage palliative care * Severe intellectual disability * Psychiatric disease hindrance * Participation in other study with psychological intervention

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anxiety disorders and symptoms are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • H.K.H. Crown Princess Victoria Children's Hospital, Linköping University Hospital, Sweden

    Linköping, 58183, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.